Mendus AB (publ)
556629-1786ActiveDeveloping immune-based cancer therapies to prevent recurrence.
Yleiskatsaus
- Tuntematon
- Työntekijät
- Tuntematon
- Liikevaihto
- 2002
- Perustettu
Avainpäättäjät
Lotta Ferm
Chief Financial Officer
Tariq Mughal
Chief Medical and Scientific Officer
Sijmen de Vries
Board Member
José Manuel Ochoa
Board Member
+15 lisää yhteystietoja Funnelfeedrissä
Kuvaus
Mendus is a clinical-stage biotechnology company dedicated to changing the course of cancer treatment. Their core mission is to address tumor recurrence, which is a major cause of cancer-related deaths, by improving long-term survival for patients. The company leverages its deep understanding of den...
Tunnisteet
Avainsanat
Teknologiat
Yritystiedot
- Toimiala
- Annan naturvetenskaplig och teknisk forskning och utveckling
- Oikeudellinen muoto
- Aktiebolag
- ALV-numero
- SE556629178601
Päättäjät
19 yhteystietoa FunnelfeedrissäLotta Ferm
Chief Financial Officer
Tariq Mughal
Chief Medical and Scientific Officer
Sijmen de Vries
Board Member
José Manuel Ochoa
Board Member
Erik Manting
Chief Executive Officer
Tanja de Gruijl
Member of the Scientific Advisory Board
Lewis Lanier
Member of the Scientific Advisory Board
Helén Tuvesson
Board Member
Sjoerd van der Burg
Member of the Scientific Advisory Board
Inge Marie Svane
Member of the Scientific Advisory Board
Gabriela Franco Salinas
Director R&D Program Management
Annelies Legters
Director Clinical Operations
Hans Preusting
Board Member
Sven Andreasson
Chairman of the Board
Ada Kruisbeek
Chair of the Scientific Advisory Board
Anneke Schuitemaker-Reurs
Director CMC & Process Development
Dharminder Chahal
Board Member
Satwinder Kaur Singh
Director Research
Ola Larsmon
Auditor in Charge
Samankaltaiset yritykset
20 samankaltaista yritystä FunnelfeedrissäActive Biotech AB (publ)
1–4 työntekijätDeveloping novel treatments for cancer and inflammatory eye diseases.
Respiratorius AB (publ)
Developing novel drugs to treat aggressive lymphoma cancers.
Ambusol AB (publ)
1–4 työntekijätPioneering patented therapy to eradicate residual glioblastoma cells post-surgery.
Spago Nanomedical AB (publ)
10–19 työntekijätSwedish nanomedicine company developing precision cancer diagnostics and therapy.
INSTITUT PRODUITS SYNTHESE (IPSEN) AB
6 työntekijätGlobal biopharma accelerating innovative medicines for high unmet needs.
Selaa lisää
Kysymyksiä yrityksestä Mendus AB (publ)
Haluatko nähdä Funnelfeedrin toiminnassa?
Varaa ilmainen demo ja tutustu siihen, miten Funnelfeedr auttaa sinua löytämään ja konvertoimaan ihanteelliset asiakkaasi.
Varaa demo